Wednesday, January 15, 2014

Newer Biologics at the ACR 2013 Meeting in San Diego

I've listed the newer biologics. Already I've marked some red as there haven't been new studies or an old study had been presented. I have already gone into detail concerning Mavrilimumab, SAN-300, and Tregalizumab. I'll have a look at other compounds soon.


No comments:

Post a Comment